ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VTYX Ventyx Biosciences Inc

3.21
-0.075 (-2.28%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -22.75M-20.4M-31.42M-38.57M-42.55M-57.15M-57.95M-50.35M
Pre Tax Income -22.73M-20.02M-30.46M-35.21M-38.93M-53.25M-54.03M-46.75M
Net Income -22.73M-20.02M-30.46M-35.21M-38.93M-53.25M-54.03M-46.75M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -22.73M-20.02M-30.46M-39.88M-42.55M-57.15M-57.96M-50.37M
EBITDA -22.73M-20.37M-31.39M-38.53M-42.52M-57.11M-57.92M-50.29M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -4.18M-7.05M-67.15M-113.14M-207.99M
Pre Tax Income -4.33M-28.17M-83.75M-108.43M-192.96M
Net Income -4.33M-28.17M-85.3M-108.43M-192.96M
Preferred Dividends 00-1.55M00
Basic Earnings Per Share (EPS) -0.235-1.43-1.692-1.903-3.268
EBIT -4.18M-7.05M-72.6M-113.1M-208.04M
EBITDA -4.18M-7.05M-67.12M-113.01M-207.84M

Your Recent History

Delayed Upgrade Clock